| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 50% | 12/24 |
| Female | 50% | 12/24 |
| Indifferent | 0% | 0/24 |
| Unknown | 0% | 0/24 |
| General | ||
| Birth Length | 0% | 0/24 |
| 8.3% | 2/24 | |
| 25% | 6/24 | |
| 12.5% | 3/24 | |
| 20.8% | 5/24 | |
| 75% | 18/24 | |
| 95.8% | 23/24 | |
| 91.7% | 22/24 | |
| 91.7% | 22/24 | |
| 47.8% | 11/23 | |
| Neurology | ||
| 95.8% | 23/24 | |
| 41.7% | 10/24 | |
| 50% | 12/24 | |
| Facial abnormalities | ||
| 8.3% | 2/24 | |
| 66.7% | 16/24 | |
| 83.3% | 20/24 | |
| 83.3% | 20/24 | |
| Visual and hearing impairments | ||
| 4.2% | 1/24 | |
| 41.7% | 10/24 | |
| Heart | ||
| 4.2% | 1/24 | |
| Pulmonary | ||
| 6.7% | 1/15 | |
| Gastrointestinal | ||
| 20.8% | 5/24 | |
| Urogenital | ||
| 8.3% | 2/24 | |
| Skeleton | ||
| 45.8% | 11/24 | |
| Skin / Hair / Nails | ||
| 41.7% | 10/24 | |
| Endocrine / Immunological / Metabolic | ||
| Endocrine | 0% | 0/24 |
| Metabolic | 0% | 0/24 |
| 16.7% | 4/24 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/24 |
| Inheritance | ||
| 95.7% | 22/23 | |
CTNNB1